Clinical Trial Update: Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) [Phase 1]

View source ↗

Summary

This update announces the Phase 1 RANT-GC trial evaluating response-adapted neoadjuvant therapy for gastroesophageal cancer, currently recruiting at the Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Adenocarcinoma

Snippet

Sponsor: University of California, Irvine | Conditions: Gastroesophageal Adenocarcinoma | Phase 1 | Status: RECRUITING